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Abstract: The physiological consequences of the activation of the immune system in 
skeletal muscle in fish are not completely understood. To study the consequences of the 
activation of the immune system by bacterial pathogens on skeletal muscle function, we 
administered lipopolysaccharide (LPS), an active component of Gram-negative bacteria, in 
rainbow trout and performed transcriptomic and proteomic analyses in skeletal muscle. We 
examined changes in gene expression in fast and slow skeletal muscle in rainbow trout at  
24 and 72 h after LPS treatment (8 mg/kg) by microarray analysis. At the transcriptional 
level, we observed important changes in metabolic, mitochondrial and structural genes in 
fast and slow skeletal muscle. In slow skeletal muscle, LPS caused marked changes in the 
expression of genes related to oxidative phosphorylation, while in fast skeletal muscle LPS 
administration caused major changes in the expression of genes coding for glycolytic enzymes. 
We also evaluated the effects of LPS administration on the fast skeletal muscle proteome 
and identified 14 proteins that were differentially induced in LPS-treated trout, primarily 
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corresponding to glycolytic enzymes. Our results evidence a robust and tissue-specific 
response of skeletal muscle to an acute inflammatory challenge, affecting energy utilization 
and possibly growth in rainbow trout. 
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1. Introduction 
In mammals, chronic infection may result in negative energy balance and muscle wasting (cachexia) 
that causes body weight loss [1]. Muscle wasting is characterized by increased proteolysis of myofibrillar 
proteins that may lead to muscle atrophy and ultimately death [2]. A signature of this state is the development 
of a systemic inflammatory process characterized by an elevation of circulating cytokines such as tumor 
necrosis factor  (TNF), that may act directly on mammalian skeletal muscle cells increasing protein 
degradation [1–3]. Additionally, skeletal muscle also has immunological capabilities and can express 
relevant surface molecules, cytokines and chemokines under inflammatory conditions [4,5]. It is known 
that mammalian skeletal muscle cells are able to recognize specific components of the external cell wall 
of Gram-negative bacteria such as lipopolysaccharide (LPS) as a response mechanism to bacterial 
pathogens. This innate immune response is based on the recognition of LPS by Toll-like receptors (TLRs) 
and the subsequent activation of cellular responses [6] that may lead to decreased muscle growth [3] as 
well as metabolic changes that can cause significant adjustments in carbohydrate, lipid and protein 
metabolism [7]. 
In contrast, the consequences of pathogenic infections on skeletal muscle function in non-mammalian 
vertebrates, such as fish, are not well documented. Interestingly, fish are believed to be less sensitive to 
the toxic effects of LPS when compared to higher vertebrates due to important differences in TLR-mediated 
recognition [8,9]. However, LPS is known to be able to induce an important inflammatory response in 
fish without the development of septic shock [10–12]. As in mammals, LPS stimulates TNF production 
in rainbow trout cultured macrophages, indicating that LPS activity and the inflammatory response 
pathways have been relatively well conserved between fish and mammals [13,14]. Given the well-described 
effects of the LPS-potentiated catabolic processes in the mammalian skeletal muscle leading to muscle 
wasting [1,2], it is conceivable that exposure to LPS in fish could also have a potential impact on skeletal 
muscle physiology and whole body homeostasis. This is important not only from a comparative 
physiological and immunological perspective but also because fish are important for human nutrition 
and particularly because skeletal muscle is the edible part of fish. It is also important to stress that the 
fish skeletal muscle, the engine for swimming, plays a fundamental role not only in locomotion, but also 
in energy homeostasis, due to the fact that this is a large, metabolically active tissue in fish (nearly 90% 
of the body mass). The metabolic status of skeletal muscle has important consequences for energy 
homeostasis in the whole organism, because lipids, carbohydrates, and proteins can be mobilized from 
this tissue and used as metabolic fuels [15]. In fish, skeletal muscle is composed of anatomically 
separated slow (red) and fast (white) muscle fibers [16]. The fibers forming the slow skeletal muscle are 
spread like a superficial sheet covering the bulk of fast fibers, representing approximately 10% and 50%, 
respectively, of body weight in fish. Both types of muscles also differ functionally, particularly in 
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relation to their contractile activity [17]. The fast muscle is typically active during burst or high-speed 
swimming and depends largely on anaerobic metabolism supported by glycolysis for energy. On the 
other hand, the slow muscle participates significantly during sustained swimming, and relies in aerobic 
metabolism obtained from oxidative phosphorylation in its mitochondria-rich fibers. Furthermore, recent 
transcriptomic analyses have revealed muscle type-specific responses to swimming in rainbow trout and 
to LPS administration in the gilthead seabream [18,19]. However, the possibility that LPS administration 
may cause muscle type-specific transcriptomic responses, or the relationship between transcriptomic and 
proteomic responses to LPS, have not been evaluated in rainbow trout (Oncorhynchus mykiss), a fish 
species of great economic interest. Therefore, the aims of this study were to investigate the effects of
in vivo administration of LPS on the transcriptome of slow and fast skeletal muscle in rainbow trout and 
to compare transcriptomic and proteomic responses to LPS in fast skeletal muscle as it represents the 
edible tissue in fish. Particularly, the evaluation of the effects of an acute LPS administration on slow 
and fast skeletal muscle may help us understand the early response of these tissues to an immunological 
challenge and how it could affect muscle metabolism and function and ultimately fish growth. 
2. Experimental Section 
2.1. Animals and Treatment 
Adult rainbow trout were purchased from a commercial hatchery (Truites del Segre, Lleida, Spain) and 
maintained under natural photoperiod in tanks with fresh open water circuits and fed with commercial 
food. For the LPS injection experiments, trout were separated into two groups (six fish in each group). 
One group was injected intraperitoneally (ip) with LPS (8 mg·kg1; E. coli clone 026:B6, Sigma L-8274, 
Sigma-Aldrich, Alcobendas, Spain) and the other group (controls) was injected with saline solution  
(0.9% NaCl). Twenty four or 72 h after injection, during which period the fish were not fed, 3 fish from 
each group were anesthetized in 3-aminobenzoic acid ethyl ester (0.1 g·L1; Sigma-Aldrich) dissolved 
in fresh water, sacrificed and slow (red) and fast (white;) skeletal muscle was dissected and frozen in 
liquid N2 until use. Both muscle samples were obtained from standarized locations: slow muscle samples 
were isolated from the midsection of the lateral line of the caudal region and fast muscle samples were 
isolated from the anterior dorsal musculature (epaxial) near the dorsal fin and care was taken to avoid 
cross-contaminating the two different muscle types. The experimental protocols used for trout in this 
study have been reviewed and approved by the Ethics and Animal Welfare Committee of the University 
of Barcelona, Spain. 
2.2. Biochemical Parameters 
Blood samples (1–2 mL) were obtained by caudal puncture and centrifuged for 4 min at 12,000× g. 
Plasma was immediately flash-frozen in liquid N2 and stored at 80 °C for subsequent analyses. Glucose, 
lactate and triglyceride levels in plasma were measured using commercial kits (Spinreact, Girona, Spain) 
and muscle glycogen was isolated and measured as previously described [20]. Results were statistically 
analyzed by Student’s t-test and were considered significant at p < 0.05. 
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2.3. RNA Extraction and cDNA Synthesis  
Total RNA from fast and slow muscle was isolated using Trizol reagent (Life Technologies, 
Barcelona, Spain), assessed for quality and quantify with a Nanodrop ND-1000 (Thermo Scientific, 
Alcobendas, Madrid, Spain), treated with a RQ1 DNAse kit (Promega, Barcelona, Spain) and 
subsequently reverse-transcribed to cDNA using SuperScript III Transcriptase (Life Technologies), 
oligo (dT) primer and random hexamer primers (Promega), according to the manufacturer’s instructions. 
2.4. Microarray Analysis 
Microarray analyses were performed on muscle samples using a rainbow trout cDNA microarray 
platform (SFA2.0 immunochip) previously validated and described [21,22] that has been deposited in 
Gene Expression Omnibus under accession number GPL6154. This microarray platform includes 1818 
unique clones each printed in six replicate spots, and is enriched in genes belonging to the following 
functional categories: immune response (236 genes), cell communication (291 genes), signal transduction 
(245 genes) and receptor activity (126 genes), apoptosis (120 genes), cell cycle (76 genes), protein 
catabolism (90 genes) and folding (70 genes), and response to oxidative stress (39 genes). This cDNA 
microarray platform has been very useful to describe global transcriptomic responses to pathogens as 
well as LPS in vivo and in vitro [10,18,23–27]. 
Equal amounts of total RNA (1 μg) from slow and fast skeletal muscle samples of individual rainbow 
trout from the control group (n = 3) and the LPS-injected group (n = 3) and at each sampling point  
(24 or 72 h), extracted as described above, were pooled and labeled with Cy3-dUTP and Cy5-dUTP  
(GE Healthcare, Barcelona, Spain) using SuperScript III reverse transcriptase (Life Technologies). The 
cDNA synthesis reaction was performed at 50 °C for 2 h in a 20 L reaction volume, followed with 
RNA degradation with 0.2 M NaOH at 37 °C for 15 min and alkaline neutralization with 0.6 M Hepes. 
Labeled cDNA was purified with Microcon YM30 (Millipore, Madrid, Spain). We used a dye swap 
experimental design and each cDNA from a pooled RNA sample was hybridized to two microarrays, 
with a total of 24 slides employed in this study. For the first slide, test and control cDNA were labeled 
with Cy5 and Cy3, respectively, and for the second array dye assignment was reversed. The slides were 
pretreated with 1% BSA, fraction V, 5 × SSC, and 0.1% SDS (30 min at 50 °C), washed with 2× SSC 
(3 min) and 0.2× SSC (3 min), and hybridized overnight in a cocktail containing 1.3× Denhardt, 3 × SSC 
0.3% SDS, 0.67 g·L1 polyadenylate, and 1.4 g·L1 yeast tRNA. After hybridization, slides were 
washed at room temperature in 0.5 × SSC and 0.1% SDS for 15 min, 0.5 × SSC and 0.01% SDS for  
15 min, and twice in 0.06 × SSC for 2 and 1 min, respectively. All chemicals were from Sigma-Aldrich. 
Scanning was performed with ScanArray 5000 and images were processed with QuantArray  
(GSI Luminomics, Munich, Germany). The measurements in spots were filtered by criteria I/B  3 
and (I  B)/(SI + SB)  0.6, where I and B are the mean signal and background intensities and SI and 
SB are the standard deviations. Low-quality spots were excluded from analysis and genes that presented 
with less than three high-quality spots on a slide were discarded. After subtraction of median background 
from median signal intensities, the expression ratios (ER) were calculated. Locally weighted non-linear 
regression normalization was performed, first for the whole slide and then for twelve rows and four 
columns per slide. To assess the differential expression of genes, the normalized log intensity ratios, or 
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difference of the mean log2 ER from zero, were analyzed for every pair of slides with reverse labeling 
(six spot replicates per gene on each slide, n = 12) with Student’s t-test (p < 0.01). Due to the large 
number of genes, the statistical significance of over represented functional categories for each type of 
muscle at the two different times was assessed using the Yates correction to Chi square test (corrected  
p < 0.05). The log2 ER-ranked up- or down-regulated genes were analyzed, interrogating the functional 
classes of Gene Ontology [28] and compared by the sums of ranked genes (Student’s t-test, p < 0.05). 
2.5. Quantitative Real-Time PCR (qPCR) 
In order to validate the results obtained from microarray analysis, quantitative real-time PCR (qPCR) 
analysis was performed in slow and fast skeletal muscle samples at 24 and 72 h after LPS administration. 
Specific primers were designed using the Genamics Expression software (www.genamics.com). Primer 
sequences and GenBank accession numbers of the target genes are presented in Table S1. The qPCR 
reactions contained 10 L of SYBR GreenER qPCR SuperMix (Life Technologies), 500 nM of forward 
and reverse primers, 3 L RNase/DNase-free water and 5 L of template DNA (cDNA at a 1:25 dilution 
or plasmid DNA), in a final volume of 20 L. The reactions were run in a MyiQ Real-Time PCR Detection 
System (Bio-Rad, Madrid, Spain) using the following protocol: 2 min at 50 °C, 8 min at 95 °C, followed 
by 40 cycles of 15 s denaturation at 95 °C and 30 s at 55 °C, and a final melting curve of 81 cycles from 
55 °C to 95 °C (0.5 °C increments every 10 s). All the samples were run in triplicate and fluorescence 
was measured at the end of every extension step. Fluorescence readings were used to estimate the Ct 
values needed to calculate the number of copies of the gene of interest. Changes in expression were 
analyzed using a previously described quantification method by qPCR [29]. Using this method, values for 
each sample were expressed as fold change, calculated relative to control group and normalized for each 
gene against 18S ribosomal RNA as the reference gene. Expression of 18S was not affected by any of 
the treatments (less than 7% difference in Ct values between control and treatment samples; p > 0.05). 
All the standard curves exhibited correlation coefficients higher than 0.99, and efficiencies were greater 
than 99%. 
2.6. Protein Extraction, Separation and Visualization 
Approximately 1 g of frozen fast muscle from pooled control or LPS treated trout (n = 3) at 24 h  
post-injection was crushed in a mortar with liquid N2. The powder was resuspended in 5 mL of 
solubilization buffer (8 M urea, 30 mM Tris-HCl pH 7.5, 2% CHAPS, 1 mM EDTA, 1 mM PMSF,  
1 g·mL1 aprotinin and 2.5 M leupeptin and pepstatin), homogenized with a Polytron and sonicated 
(5 × 30 s bursts). After homogenization, the cell extract was centrifuged at 100,000× g for 60 min at  
4 °C. Supernatants were recovered and frozen at 80 °C until use. An aliquot of cell extract was used to 
determine protein concentration with the Bio-Rad protein assay using BSA as a standard. Protein samples 
(500 g) were adjusted to a final volume of 450 L in rehydration buffer (8 M urea, 0.5% CHAPS,  
0.2% DTT) with ampholines (0.5% v/v). Isoelectrofocusing (IEF) was performed in 24 cm IPG strips 
pH 3–11 non-linear (GE Healthcare). Once IEF was completed the strips were equilibrated first in  
10 mL equilibration buffer (2% SDS, 50 mM Tris-HCl pH 8.6, 6 M urea, 30% glycerol (v/v), 0.002% 
bromophenol blue) plus 100 mg DTT for 15 min under shaking, and secondly in 10 mL equilibration 
buffer plus 250 mg iodoacetamide for 15 min under shaking. Separation by protein mass was carried out 
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using an EttanDalt electrophoresis unit (GE Healthcare) on homogenous polyacrilamide gels (12.5%) 
until the front of bromophenol blue dye reached the bottom of the gel. Gels were stained with Coomassie 
R 350 Stain (PhastGel blue R, GE Healthcare) or Silver stain, scanned with an ImageScanner  
(GE Healthcare) and analyzed using ImageMaster 2D Elite 3.1 software (GE Healthcare, Little Chalfont, 
UK; 2000). Qualitative differences in the abundance of differential protein spots were evaluated and 
these spots were identified by mass spectrometry (see below). 
Table 1. Validation of microarray results by qPCR for selected genes in response to LPS a. 
GeneBank ID Clone Name 
Slow Muscle Fast Muscle 
24 h 72 h 24 h 72 h 




  1.75 1.20 1.44 1.20   
BX074486 Heat shock protein HSP 90-beta-2     1.25 73.51   
CX146261 
Myosin light chain 1,  
skeletal muscle isoform 
  3.78 14.32     
CU069718 Parvalbumin alpha-3 1.82 4.59 74.54 592.22 1.99 5.86 2.38 5.54 
DY467707 Serine protease-like protein-1   2.23 3.39 1.34 1.83   
CA039449 Tropomyosin alpha 3 chain-2   2.11 37.79     




    1.27 22.32   
a Results obtained by qPCR are expressed as fold change with respect to the control (saline-injected) group, which was set to 1, with each 
sample performed in triplicate. Microarray results (MA) are expressed as fold change over control. 
2.7. Protein Identification by Mass Spectrometry (MS) 
Protein spots that were found to be differentially abundant were excised from the gel with a scalpel and 
digested with trypsin (Sequencing grade modified, Promega). Briefly, proteins were washed sequentially 
with ammonium bicarbonate buffer and destained with 50% acetonitrile (ACN). Proteins were reduced 
by treatment with 10 mM DTT and alkylated for 30 min with 100 mM iodine acetamide. They were then 
sequentially washed and digested overnight at 37 °C with 0.27 nM trypsin. Tryptic peptides were extracted 
from the gel with 10% formic acid and ACN and extracts were pooled and dried in a vacuum centrifuge. 
Proteins were either analyzed by MALDI-TOF/TOF MS (4700 Proteomics Analyzer, Applied Biosystems, 
Framingham, MA, USA) or LC-MS/MS (Q-TOF Global, Micromass-Waters, Manchester, UK). In the 
first case, the digests were redissolved in 5 L of 0.1% trifluoroacetic acid (TFA) in 50% ACN. 
Typically, a 0.5 L aliquot was mixed with the same volume of a matrix solution, 5 mg·mL1 -ciano-4-
hydroxycinnamic acid (Waters, Barcelona, Spain) in 0.1% TFA in 50% ACN, and directly spotted onto a 
MALDI-plate. MS spectra were acquired and three major peaks were selected for further 
characterization by MS/MS analysis. Spectra were submitted for database searching in a generic 
MASCOT format. Some of the tryptic digested peptide samples (spots number 10–12 in Table 1) were 
analyzed by on-line LC-MS/MS (Cap-LC-nano-ESI-Q-TOF, CapLC, Micromass-Waters). In those 
cases, samples were re-suspended in 12 L of 10% formic acid solution and 4 L were injected for 
chromatographic separation in a reverse-phase capillary C18 column (75 m of internal diameter and  
15 cm length, PepMap column, LC Packings). The eluted peptides were ionized via coated nano-ES 
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needles (PicoTipTM, New Objective). A capillary voltage of 1800–2200 V was applied together with a 
cone voltage of 80 V. The collision in the CID (collision-induced dissociation) was 20–35 eV and argon 
was employed as collision gas. Data were generated in PKL file format and were submitted for database 
searching in MASCOT server. Proteomic analyses were performed at the Proteomics Platform of the  
Parc Cientific de Barcelona at the Universitat de Barcelona. 
3. Results and Discussion 
In the present study, we investigated the transcriptomic and proteomic response of skeletal muscle to 
an acute immunological challenge in order to understand the physiological response of rainbow trout to 
bacterial pathogens. For this purpose, we simulated the effects of a bacterial infection in rainbow trout 
by in vivo administration of LPS, an activator of the fish innate immune system known to induce an 
inflammatory response in this species [11,27,30]. 
3.1. Metabolic Effects of LPS Administration in Rainbow Trout 
We first evaluated the metabolic effects of an acute immune challenge on skeletal muscle in rainbow 
trout by measuring the levels of plasma metabolites (i.e., glucose, lactate and triglycerides) and fast 
muscle glycogen content at 24 and 72 h after an intraperitoneal injection of LPS or saline. The plasma 
levels of glucose and lactate were not significantly altered in response to LPS administration at 24 or 72 h 
post-injection (Figure 1A,B). However, triglyceride plasma levels decreased in LPS-injected fish relative 
to controls, although only significantly at 24 h (Figure 1C). In addition, glycogen levels in fast skeletal 
muscle were similar between control and LPS-injected fish at 24 h but were significantly lower in  
LPS-injected fish at 72 h (Figure 1D). These results suggest that LPS injection in fish may have caused 
an increase in the utilization of energy sources in the form of circulating triglycerides (lipids) and fast 
muscle glycogen (carbohydrate) stores. The observed metabolic response to LPS administration in 
rainbow trout is similar to the consequences of a systemic inflammatory response (sepsis) caused by 
microbial infections in mammals that are characterized by an increase in the use of glucose by the 
mammalian host, sometimes followed by a transient hyperglycemia, lactate production, metabolic acidosis 
and glycogen depletion [31,32]. Therefore, as in mammals, fish may also undergo metabolic changes in 
response to LPS to likely cover the increased energetic demand caused by an inflammatory insult. 
3.2. Transcriptomic Analysis of Fast and Slow Skeletal Muscle in Response to LPS Administration in 
Rainbow Trout 
Transcriptomic analysis of trout skeletal muscle was performed using a microarray platform (SFA2.0) 
previously validated for studies involving response to stress and toxicity [21,22], as well as the immune 
response in trout [10,11,33]. Our results indicate that LPS administration significantly altered the 
expression of 131 genes in fast muscle after 24 h (p < 0.01), with 59 genes up-regulated and 72 genes 
down-regulated. At 72 h after LPS administration, 304 differentially expressed genes (DEGs) were found 
in fast muscle, 156 genes up-regulated and 148 genes down-regulated. In slow muscle, a similar number 
of DEGs were found at 24 h after LPS administration as in fast muscle: 135 DEGs, with 77 genes  
up-regulated and 58 genes down-regulated. In contrast, 226 genes were differentially expressed at 72 h 
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in slow muscle, with 120 genes up-regulated and 106 genes down-regulated. Validation of the 
microarray data was performed by qPCR of eight DEGs for both slow and fast muscle (Table 1). We 
selected a similar number of genes up- and down-regulated included in several functional categories. In 
all cases, the direction and magnitude of changes in expression were confirmed by qPCR. 
 
Figure 1. Changes in metabolite levels in plasma and fast skeletal muscle of trout at 24 or 
72 h after saline (white bars) or lipopolysaccharide (black bars) injection. (a) Glucose;  
(b) lactate and (c) triglyceride concentrations in plasma are expressed as mM, where  
(d) glycogen levels in fast muscle are expressed in mg·g1. Values shown are means ± SE of 
six fish per group, each analyzed in triplicate. Significant differences between control and 
treatment groups are shown with asterisks (p < 0.05). 
In a first instance, the gene expression data were analyzed by functional categories to evidence overall 
transcriptomic differences between the two types of skeletal muscle. An initial analysis of over 
represented Gene Ontology categories provided a first view of the transcriptomic response of slow and 
fast muscle over time after LPS administration (Figures S1 and S2). This analysis evidenced altered 
expression of defense and immune responses as well as muscle development and contraction in slow and 
fast muscle that intensified from 24 to 72 h after LPS administration. The major difference in over 
represented categories between the two tissues was the significantly altered expression of the categories 
related to mitochondria only in slow muscle at 72 h after LPS administration (Figure S1). Further 
analysis identified several functional categories that were significantly (p < 0.05) differentially expressed 
in fast or slow muscle in response to LPS administration (Figures 2 and 3). 
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Figure 2. Gene Ontology analysis for slow skeletal muscle at 24 h (black bars) and 72 h 
(grey bars) after lipopolysaccharide (LPS) administration in trout. Differentially expressed 
genes (DEGs) were grouped by gene ontology functional categories and fold change 
differences were analyzed by Student’s t-test (p < 0.05). TGC indicates the total number of 
genes included in each functional category. Data are shown as mean fold change. 
In slow muscle, functional categories altered by LPS administration included mitochondrion and 
electron transport (both up-regulated at 72 h), cytoskeleton, muscle development (up-regulated at 24 h 
but down-regulated at 72 h), glycolysis (down-regulated at 24 and 72 h) and immune response  
(up-regulated at 72 h) (Figure 2). In fast muscle, LPS administration caused changes in the expression 
of functional categories related to carbohydrate metabolism (e.g., glycolyis; down-regulated at 24 h but 
up-regulated at 72 h), protein metabolism (e.g., protein biosynthesis and modification), muscle 
development (up-regulated at 24 and 72 h), nuclear activity and transcription, apoptosis and immune 
response (up-regulated at 72 h) (Figure 3). Within these differentially expressed functional categories, 
the individual value and direction of change for representative genes are detailed in Table 2 and the full 
list of DEGs in slow and fast muscle at 24 and 72 h after LPS administration can be found in Tables S2 
to S5, respectively. 
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Figure 3. Gene ontology analyses of genes expressed in fast skeletal muscle at 24 h (black bars) 
and 72 h (grey bars) after lipopolysaccharide (LPS) administration in trout. Differentially 
expressed genes (DEGs) were grouped by gene ontology functional categories and fold change 
differences were analyzed by Student’s t-test (p < 0.05). TGC indicates the total number of 
genes included in each functional category. Data are shown as mean fold change. 
Within the functional category of carbohydrate metabolism we observed a significant (p < 0.05)  
up-regulation of the mRNA expression levels of genes involved in glycogen breakdown (glycogen 
phosphorylase-2), glycolysis (beta-enolase and glyceraldehyde-3-phosphate dehydrogenase), and 
gluconeogenesis (glucose-6-phosphate isomerase) in fast muscle at 72 h after LPS administration that 
was preceded by a significant down-regulation of most of these genes at 24 h after LPS administration 
(Tables 2, S4 and S5). The mRNA expression levels of 6-phosphofructokinase (6-PFK), a key glycolytic 
enzyme, were decreased by LPS administration in fast muscle at both 24 and 72 h, suggesting a tight 
regulation of this metabolic pathway during endotoxin treatment as in the mammalian muscle [34]. In 
contrast, in slow muscle we observed a marked down-regulation, particularly at 72 h, of DEGs involved 
in carbohydrate metabolism including several important genes involved in glycolysis (e.g., beta-enolase, 
glyceraldehyde-3-phosphate dehydrogenase and 6-PFK) (Tables 2, S2 and S3). 
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Table 2. Differentially expressed genes representative of various physiological processes in 
slow and fast skeletal muscle at 24 and 72 h after lipopolysaccharide administration in 
rainbow trout a. 
Clone Name Slow Muscle Fast Muscle 24 h 72 h 24 h 72 h 
Carbohydrate metabolism     
Beta enolase-3  2.85  2.41 
6-phosphofructokinase 1.53  1.88  
Glyceraldehyde-3-phosphate dehydrogenase-5  1.84 1.61 1.66 
Glycogen phosphorylase-2   1.99 1.51 
Fructose-1,6-bisphosphatase isozyme 2  1.62   
Glucose-6-phosphate isomerase-1      3.10 
Protein synthesis/catabolism/modification     
40S ribosomal protein S9-3  1.51  1.77 
60S ribosomal protein L13a-acute pahse protein    2.14 
60S ribosomal protein L32-2  1.88  2.08 
Cathepsin D     1.66 
Proteasome activator complex subunit 2 1.60  1.83  
Proteasome subunit alpha type 7-2    3.84 
Proteasome subunit beta type 9 precursor 2.01 1.49  1.88 
Serine protease-like protein-1  2.23  1.78 
Ubiquitin  3.73  265.03 
Muscle development/cytoskeleton     
Actin, alpha skeletal 3 1.73 3.53  1.87 
Creatine kinase, M-3  2.75   
Myosin heavy chain, skeletal, adult 1-2  3.32  1.51 
Myosin light chain 2-2 1.77 5.94  3.20 
Parvalbumin alpha-3 1.82 74.54 1.99 2.38 
Troponin I-4, fast skeletal muscle 1.72 5.54 1.58 3.76 
Tropomyosin alpha 3 chain-2  2.11   2.55 
Immune response     
Beta-2-microglobulin-1 2.13  1.52 1.56 
CC chemokine SCYA110-2 2.14  2.97  
Ferritin heavy chain-1    1.62 
Ig kappa chain V-IV region B17-2 1.58 3.41   
Lysozyme C precursor  1.59  2.17 
Macrophage receptor MARCO 1.60   1.59 
MHC class 1b antigen 2.45  1.64 2.36 
MHC class II invariant chain-like protein 1 1.60 2.19   2.06 
Lipid metabolism     
Apolipoprotein A-I-1    4.56 
Apolipoprotein E-2  1.72   
Fatty acid-binding protein-1 1.62 1.68 1.64 2.17 
Acyl-Coenzyme A dehydrogenase, long chain  2.46    
Mitochondrion/electron transport     
ATP synthase coupling factor 6, mitochondrial  2.19   
Cytochrome b-1  1.73  1.71 
Cytochrome oxidase subunit III-2  2.89   
NADH dehydrogenase subunit 5-1  7.21 1.53 1.89 
a Data shown represent mean fold change (FC) over control. Significantly up- and down-regulated genes  
(p < 0.01, Student’s t-test, 12 spot replicates per gene, 1.5 < FC > 1.5) are highlighted with a color scale. 
> 4 2 to 4 1.5 to 2 1.5 to 2 2 to 4 < 4 
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LPS administration in trout also caused significant changes in the mRNA expression levels of genes 
involved in protein metabolism, as shown by the large number of DEGs involved in protein biosynthesis 
as well as in protein modification and catabolism. In particular, this functional category included DEGs 
coding for several ribosomal proteins (e.g., 40S, 60S) in both types of muscle. In fast muscle, most of 
these genes were down-regulated at 24 h and up-regulated at 72 h, contrary to the situation in slow 
muscle (Tables 2, S4 and S5). Among genes involved in protein modification and catabolism, we 
highlight the altered expression of cathepsin D, proteasome subunits, serine proteases and ubiquitin in 
fast and slow muscle in response to LPS administration. Interestingly, LPS administration also caused 
changes in the functional category of muscle development in trout fast and slow muscle (Figures 2 and 3) 
that included genes coding for proteins participating in the contractile apparatus of skeletal muscle fibers 
(e.g., alpha actin, myosin heavy chain 1, myosin light chain 2, troponin I-4, tropomyosin alpha 3) and in 
the regulation of contraction (e.g., parvalbumin alpha-3, creatine kinase M-3) (Table 2, Tables S2 to S5). 
Specifically, most DEGs involved in muscle development were up-regulated in fast muscle of  
LPS-injected trout at 24 and 72 h, whereas they were up-regulated in slow muscle at 24 h but strongly 
down-regulated at 72 h. The parallel increase in the expression of genes involved in protein synthesis 
and muscle development in fast muscle in response to LPS suggests that endotoxin administration in fish 
may induce metabolic and structural changes that may be linked to a muscle remodeling process. 
However, we cannot discard the possibility that the rate of protein synthesis may not vary concurrently 
with gene expression in skeletal muscle of LPS-injected trout, as it has been suggested for the rat skeletal 
muscle during sepsis [35]. Nevertheless, the notion that LPS may induce muscle remodeling is reinforced 
by data on the increased expression of genes involved in protein degradation in fast and slow muscle of 
LPS-injected trout. Similar results, although with some differences in time-related expression changes, 
were reported in a previous study from our group on the muscle transcriptomic response of another teleost 
species, the seabream (Sparus aurata), to LPS administration [18]. Therefore, we hypothesize that an acute 
administration of LPS in fish may result in the preservation of fast muscle that may otherwise be 
possibly used as fuel [36]. However, the different response of slow muscle to LPS administration in trout 
(i.e., decreased expression of genes involved in protein synthesis and in muscle development) is 
reminiscent of an atrophy phenotype, as previously described in this species [37]. Given the observed 
alteration in the expression of genes important for skeletal muscle function, it would be important to 
determine in future studies if an acute challenge with LPS can affect swimming performance in trout 
and/or muscle contractile characteristics. In contrast to the acute effects of LPS described here, a chronic 
stimulation with LPS in trout (over 43 days) was reported to reduce skeletal muscle growth, although 
without changes in the mRNA levels of growth marker genes (e.g., myosins) [38]. Therefore, the results 
from these studies suggest that inflammatory conditions in fish could result in alterations in protein 
metabolism that could eventually affect muscle growth. 
Interestingly, an acute LPS administration in trout, previously shown to induce a potent inflammatory 
response in both the head kidney and in the spleen [11,27] involving increased expression of the antigen 
presentation machinery and a vast array of anti-bacterial products, resulted in changes in the expression of 
genes involved in the immune response in fast and slow muscle. The effects of LPS were particularly 
noticeable at 72 h after LPS administration in both types of muscle, causing an up-regulation of the 
expression of genes involved in antigen presentation (e.g., MCH class I and II, beta-2-microglobulin-1), in 
the degradation of mucopolysaccharide from the bacterial wall (e.g., lysozyme C) and in iron sequestering 
(e.g., ferritin heavy chain-1). The general up-regulation of immune-related genes observed in this study 
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is consistent with the previously reported increased expression of immune genes in trout skeletal muscle 
after chronic LPS treatment, including lysozyme [38]. However, it is not known if the detected immune 
genes are expressed in skeletal muscle cells or in immune cells present in this tissue. In mammals, the 
expression of immune molecules by macrophages infiltrated in skeletal muscle appears to be essential 
during tissue repair, stimulating myogenesis and fiber growth [39]. These types of mechanisms cannot 
be discarded in trout, although such episodes appear to be significant, at least in mammals, only in lesioned 
muscle [40,41] and probably do not reflect the changes in the gene expression profile of skeletal muscle 
identified in our study. In this respect, several studies have shown that the response of the mammalian 
skeletal muscle to endotoxin exposure stimulates antigen presentation, which elicits an immune response 
by inducing the production of immune molecules such as MHC molecules, adhesion molecules and 
cytokines [4]. In mammals it is well known that the skeletal muscle possesses many of the components 
of the innate immune system, including the presence of toll-like receptors and the ability to produce 
cytokines [42]. In the mammalian skeletal muscle, binding of LPS to its receptor (TLR-4) promotes the 
synthesis and secretion of inflammatory cytokines such as TNF [43], which has multiple metabolic 
effects, including the regulation of lipid metabolism through the activation of lipolysis [44–46]. Despite 
the lack of TLR4 in the rainbow trout and the unresolved question of whether LPS action is mediated by 
TLRs in fish [47], a conservation of this inflammatory response pathway may be present in trout tissues 
because LPS directly increases TNF mRNA levels and TNF protein secretion by cultured trout 
macrophages [13,48] and in vivo administration of LPS increases TNF mRNA levels in trout skeletal 
muscle and ovarian tissue [33,38]. Interestingly, LPS administration in vivo in trout is known to increase 
the basal lipolytic rate in isolated trout adipocytes in vivo and TNF directly stimulates lipolysis in trout 
adipocytes in vitro [49]. In the present study, the observed decrease in the plasma levels of triglycerides in 
response to LPS administration in trout (at 24 h) is consistent with the notion of a catabolic role of LPS on 
lipid metabolism that may be mediated by TNF. Although we do not know whether LPS can act directly 
on skeletal muscle cells, we hypothesize that LPS administration in trout may have stimulated TNF 
production that, in turn, may have increased the entry of lipids into skeletal muscle, primarily in slow 
muscle as suggested by the increased expression of genes involved in lipid transport (e.g., apolipoproteins 
A-I and E-2, fatty acid binding protein-1), and their catabolism, as suggested by the increased 
expression of Acyl-CoA dehydrogenase (Table 2), an enzyme that catalyzes the first step of mitochondrial 
fatty acid beta-oxidation. Our results suggest that lipids could have a preponderant role fulfilling the 
increase in energy demand during the early stages in the response of trout to an acute endotoxin 
exposure. Additionally, triglycerides included in circulating lipoproteins may have an important role 
against LPS-induced toxicity and have been considered an important component of an innate, non-adaptive 
immune response of the host to a bacterial infection [50]. 
3.2.1. Muscle Type-Specific Responses to LPS Administration 
In order to identify specific responses to LPS in each of the two types of skeletal muscle, we performed a 
comparative analysis at 24 and 72 h after LPS administration (Figure 4a). At 24 h after LPS administration, 
101, 97 and 34 DEGs were found only in slow muscle, only in fast muscle and in both tissues, respectively. 
At 72 h, 101, 125 and 179 DEGs were found only in slow muscle, only in fast muscle and in both tissues, 
respectively. LPS administration produces in trout a notable contrasting effect in the expression of genes 
related to protein synthesis (e.g., several ribosomal components) between both muscle types, particularly 
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after 72 h, that were down-regulated in slow skeletal muscle and up-regulated in fast skeletal muscle. 
Furthermore, such changes were accompanied by differential expression of several genes involved in protein 
modification and catabolism, that included cathepsins, proteasome subunits, proteases and ubiquitin related 
proteins in both types of muscle. We note the specific expression in fast muscle of genes involved in 
protein synthesis (e.g., ribosomal proteins), calcium storage (e.g., calmodulin-1), carbohydrate metabolism 
(e.g., glycogen phosphorylase-1 and glucose phosphate isomerase-1) and lipid metabolism (e.g., 
apolipoprotein A), all significantly up-regulated at 72 h after LPS administration. Moreover, forkhead box 
protein O3A, an important factor in energy balance, was also expressed exclusively in fast muscle and 
was down-regulated (Figure 4b). Among genes that were differentially expressed exclusively in red muscle 
we highlight creatine kinase B and several forms of cytochromes involved in energy generation (e.g., 
cytochrome b-3, cytochrome c oxidase subunits I-1 and III-2), together with skeletal myosin heavy chain 
involved in contractile activity in muscle (Figure 4b). Parallel to this response, the expression of genes 
encoding contractile and structural elements in skeletal muscle (troponin, tropomyosin, actin, and 
myosin) was down-regulated in slow skeletal muscle but up-regulated in fast skeletal muscle, reinforcing 
the idea that LPS administration exerts a muscle-specific transcriptomic response. In addition to 
evaluating the tissue-specific responses to LPS as described above, in order to understand how fast and 
slow skeletal muscles respond to LPS it is also useful to examine the expression of those genes that 
appear differentially expressed in both tissues, regardless of the direction of change (Tables S5 and S6). 
Most notably, this type of analysis, particularly at 72 h after LPS administration, clearly evidences the 
contrasting regulation of structural and contractile elements between the two types of muscle, with 
up-regulation in fast muscle and down-regulation in slow muscle (Table S6). 
 
Figure 4. Muscle type-specific responses to lipopolysaccharide (LPS) administration in 
trout. (a) Venn diagrams showing the number of slow skeletal muscle differentially expressed 
genes (DEGs; p < 0.01), fast skeletal muscle DEGs, and common DEGs at 24 and 72 h after 
LPS administration in trout; (b) List of selected DEGs specific for slow and fast muscle in 
response to LPS administration. Data shown represent mean fold change (FC) over control. 
Significantly up- and down-regulated genes (p < 0.01, Student’s t-test, 12 spot replicates per 
gene, 1.5 < FC > 1.5) are highlighted with a color scale. 
Slow muscleb) Fast muscle
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Clone ID Clone Name 24 h 72 h
BX877482 Aldehyde dehydrogenase 9 A1-2  -2.80 
BX077754 Creatine kinase, B chain -2.48
CV428906 Cytochrome b-3 -1.54 2.47 
CX016176 Cytochrome c oxidase subunit I-1  2.04 
EG814116 Cytochrome oxidase subunit III-2 2.88
CU071943 Galectin-9 (VHSV-induced protein)-2 1.65  
DY735078 Ig kappa chain V-IV region B17-2 1.58 3.40 
BX861962 Myosin heavy chain, skeletal, fetal -2.35
 
Clone ID Clone name 24 h 72 h 
CR_5 14-3-3 E1  -1.92 
CR_8 14-3-3 G2  2.77 
CX141783 60S ribosomal protein L13a-acute phase  2.14 
CA381199 94 kDa glucose-regulated protein 1.74  
CX245881 Apolipoprotein A-I-1 1.27 4.57 
CA051935 ATP-binding cassette, sub-family F, member 2 -1.52  
CA368739 BCL2-associated athanogene 1  -1.74 
CA367764 Calmodulin-1 -1.85 1.55 
CA367914 Forkhead box protein O3A  -2.10 
CA371363 Glucose-6-phosphate isomerase-1  3.09 
EH033491 Glycogen phosphorylase-1 -2.11 1.76 
CA362083 Polyposis locus protein 1  -2.28 
CU063628 Proteasome subunit alpha type 7-1 -1.51 -4.52 
CU075994 Ring finger protein 10  -1.51 
CA361724 Signal transducer activator of transcription 3 1.83 -2.56 
EG797214 Synaptic glycoprotein SC2-2 -1.61  
BX883521 T-cell lymphoma associated antigen se33-1  -2.47 
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3.3. Proteomic Analysis of Fast Skeletal Muscle in Response to LPS Administration in Rainbow Trout 
In order to integrate the described transcriptomic response of skeletal muscle to LPS administration 
with possible changes at the protein level, we performed a proteomic analysis of the trout fast muscle at 
24 h after the LPS challenge, given that fast muscle represents most of the consumable flesh in fish. 
Using two-dimensional electrophoresis (2-DE) we detected ~100 protein spots in the fast muscle of trout, 
with Mr values between 20,000–120,000 and pI values between 4–9 (Figure 5a). Comparison between 
LPS and control samples among three replicates showed high similarity in the spots analyzed. Analysis 
of gels from these experiments showed an induction of several proteins in fast muscle in response to 
LPS challenge (p < 0.005), as shown by the changes in the intensity in most of the spots visualized with 
Coomassie staining (Figure 5a). 
 
Figure 5. Proteomic changes in trout fast skeletal muscle after lipopolysaccharide (LPS) 
administration. (a) Representative bi-dimensional Coomassie stained 2-DE gels of pooled 
fast skeletal muscle samples from trout injected with saline (Control; n = 3) or LPS (n = 3), 
performed in triplicate. In the control gel, the spots circled in red indicate proteins identified 
by MALDI/TOF; (b) Identification of proteins separated by 2-DE. Database accession 
numbers are indicated as a GI number. MASCOT score greater than 72 indicates that the 
protein identification is significant (p < 0.05). The qualitative direction of change of 
identified proteins in LPS versus control gels is indicated by arrows. = indicates absence of 
visual changes in spot intensity. 
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Fourteen protein spots obtained from Coomassie-stained gels were excised and analyzed by MALDI-
TOF-MS for identification. The selected spots showed qualitative differences in intensity or pI between 
control and LPS-treated trout and corresponded to proteins engaged in muscle contraction (e.g., myosin 
light chain and fast myotomal muscle tropomyosin), enzymes involved in energy metabolism, mainly 
glycolysis (e.g., phosphoglucomutase, enolase, glyceraldehyde 3-phosphate dehydrogenase, aldolase, 
phosphoglycerate mutase, triosephosphate isomerase and lactate dehydrogenase), and energy 
homeostasis (e.g., creatine kinase and adenylate kinase) (Figure 5b). In some cases (e.g., lactate 
dehydrogenase, creatine kinase and enolase), the analysis of the protein spots reflected changes in the 
mobility of these proteins as a consequence of differences in pI or Mr. The exception to these described 
changes in proteins from muscle samples from LPS-treated trout occurred with the enzymes glyceraldehyde  
3-phosphate dehydrogenase and aldolase, whose spots remained unchanged in pI, Mr or intensity when 
compared to control trout (Figure 5b). Interestingly, the increase in the protein content of several glycolytic 
enzymes (phosphoglucomutase, enolase, phosphoglycerate mutase, and triosephosphate isomerase) in 
fast muscle of trout in response to LPS administration (at 24 h after injection) is related to the observed 
up-regulation, as assessed by microarray analysis, of the expression of genes involved in glycogen breakdown 
(glycogen phosphorylases) and glycolysis (enolase and glyceraldehyde-3-phosphate dehydrogenase). 
This is also supported by the decrease in glycogen levels in fast skeletal muscle in LPS-injected fish at 
72 h, suggesting an increase in the utilization of fast muscle glycogen stores. Although plasma levels of 
glucose were not significantly altered in response to LPS administration, it is possible that glucose 
utilization for energy derivation was increased in fast muscle, as suggested by the significantly altered 
expression of genes involved in carbohydrate metabolism, nutrient oxidation and ATP synthesis-coupled 
electron transport in this tissue (Figure 3 and Figure S2). We hypothesize that the observed increase in 
glycogenolysis in fast muscle of trout may be caused by the higher glucose demands imposed after 
endotoxin exposure, as has been suggested in the mammalian muscle [51]. However, it can be argued that 
the transcriptomic and proteomic analyses of trout fast muscle at 24 h after LPS exposure suggest a 
diverging pattern in glycolysis, as shown by the down-regulation at the gene expression level and the 
increase in protein content of enzymes in this metabolic pathway. It is well known that changes in gene 
expression and protein levels may not necessarily correlate, sustaining the necessity to complement 
transcriptomic with proteomic approaches [52,53]. However, the decrease in the mRNA expression 
levels of genes coding for glycolytic enzymes was reverted at 72 h after LPS exposure, reinforcing the 
importance of this metabolic pathway in providing energy to the trout fast muscle. Similar contrasting 
conclusions between transcriptomic and proteomic studies were obtained in zebrafish subjected to 
hypoxia [54,55] as the gene expression program may display a delay with respect to protein synthesis. 
Overall, the changes in metabolic enzymes at the protein and mRNA level in fast muscle in response to 
LPS administration are suggestive of an enhanced importance for carbohydrate utilization in fast muscle, 
the largest tissue in the body, under proinflammatory conditions such as those elicited by LPS 
administration. In addition to glycolysis, contractile elements and regulatory factors in fast muscle also 
showed parallel transcriptomic and proteomic changes. In particular, myosin light chain 2, a protein 
identified in two different spots as more abundant under LPS treatment, also showed increased mRNA 
expression levels (myosin light chain 2.1 and 2.2) by microarray analysis in fast muscle at 72 h after 
LPS administration (Table S5). These changes in the expression of specific contractile elements in fast 
muscle both at the proteomic and transcriptomic levels are in agreement with the general increase of the 
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expression of genes involved in functional categories related to muscle contraction and development in 
fast skeletal muscle in response to LPS administration in rainbow trout. A similar up-regulation of 
functional categories related to contractile and structural elements of fast skeletal muscle was observed 
in the gilthead seabream in response to LPS administration [18] and points towards a common response of 
the fish fast muscle to a challenge with LPS possibly to safeguard proteins involved in muscle 
contraction and, therefore, important for swimming performance. 
4. Conclusions
In the present study, by applying a combination of transcriptomic and proteomic analyses to investigate 
the regulation of skeletal muscle function in rainbow trout subjected to a proinflammatory insult, we 
show that an acute treatment with LPS in rainbow trout results in alterations in metabolic parameters in 
the blood and in transcriptomic and proteomic changes in skeletal muscle. Most notably, our results 
strongly suggest that LPS administration may have promoted carbohydrate metabolism in fast muscle to 
generate energy from glucose by mobilizing glycogen stores and by stimulating glycolysis in fast muscle. 
Similarly, our results suggest that LPS may have caused an increase in the utilization of lipids as a source 
of energy. In view of these apparent catabolic effects, it is surprising that LPS administration induced the 
expression of genes involved in protein synthesis and degradation coupled with increased expression of 
sarcomeric contractile elements in fast muscle, perhaps as part of a compensatory muscle remodeling 
process in the face of a metabolic challenge. Overall, the results from this study indicate that LPS 
administration in rainbow trout has a significant impact on skeletal muscle physiology and may alter 
whole body energy homeostasis. Further studies are needed to understand how immune challenges can 
affect energy use and growth in fish. 
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